Morishige Takeshita

Morishige Takeshita

Auto-generated profile, based on publicly available information

Morishige Takeshita

Graduate School of Medical Sciences, Fukuoka University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2012 in Virchows Archiv
Verified
Journal Article
Open access
PDF file
KKKanta Kikuma
Kanta Kikuma
JWJiro Watanabe
Jiro Watanabe
YOYumi Oshiro
Yumi Oshiro
TSTatsuo Shimogama
Tatsuo Shimogama
YHYumi Honda
Yumi Honda
MTMorishige Takeshita
Morishige Takeshita
Sixty-four cases of malignant lymphoma involving the liver were examined. Of these, 20 cases were histologically confirmed to be primary hepatic B-cell lymphoma. Twelve of these 20 cases were diffuse large B-cell lymphoma (DLBCL) and eight cases were mucosa-associated lymphoid tissue (MALT) lymphoma. Of the 12 cases of DLBCL, six were immunohistologically positive for CD10 and/or Bcl6 (indicating a germinal center phenotype), six were positive for Bcl2, and five were positive for CD25. Eight of the 12 DLBCL cases (66.7%) and two of the eight MALT lymphoma cases (25%) had serum anti-hepatitis C virus (HCV) antibodies and HCV RNA. The incidence of HCV infection was significantly higher in the hepatic DLBCL cases than in systemic intravascular large B-cell cases with liver involvement (one of 11 cases, 9.1%) and T/NK-cell lymphoma cases (one of 19 cases, 5.3%) (p < 0.01 for both). Two hepatic DLBCL cases (16.7%) had rheumatoid arthritis treated with methotrexate, and four MALT lymphoma cases (50%) had Sjögren’s syndrome, primary biliary cirrhosis, or autoimmune hepatitis; one case in each of these two groups was complicated by chronic HCV-seropositive hepatitis. Although primary hepatic lymphoma is rare, persistent inflammatory processes associated with HCV infection or autoimmune disease may play independent roles in the lymphomagenesis of hepatic B cells.

16 February 2011 in Histopathology
Verified
Journal Article
Closed access
PDF file
MTMorishige Takeshita
Morishige Takeshita
SNShotaro Nakamura
Shotaro Nakamura
KKKanta Kikuma
Kanta Kikuma
YNYoshifuku Nakayama
Yoshifuku Nakayama
SNSatoshi Nimura
Satoshi Nimura
AIAkinori Iwashita
Akinori Iwashita

1 June 2014 in Human Pathology
Verified
Journal Article
Closed access
KKKanta Kikuma
Kanta Kikuma
KYKozue Yamada
Kozue Yamada
SNShotaro Nakamura
Shotaro Nakamura
AOAkiko Ogami
Akiko Ogami
SNSatoshi Nimura
Satoshi Nimura
MTMorishige Takeshita
Morishige Takeshita

25 July 2016 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
HIHideki Ishibashi
Hideki Ishibashi
SNSatoshi Nimura
Satoshi Nimura
YKYoshiyuki Kayashima
Yoshiyuki Kayashima
YTYasushi Takamatsu
Yasushi Takamatsu
KAKunihiko Aoyagi
Kunihiko Aoyagi
MTMorishige Takeshita
Morishige Takeshita
In East Asia, monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL), previously known as type II enteropathy-associated T-cell lymphoma (EATL), occurs more frequently than type I EATL, and coeliac disease is rare. Here we present four cases of MEITL in Japanese patients, including the endoscopic and pathological findings of their duodenal and colorectal lesions. Tumor specimens obtained from duodenal, intestinal, and colorectal biopsies in all four patients showed a diffuse intramucosal infiltration of small to/or medium-sized lymphoma cells and numerous atypical intraepithelial lymphocytes (IELs). These cells were immunohistologically positive for CD103, CD3, CD7, CD8, CD56, and T-cell intracellular antigen-1. Upper and lower gastrointestinal and antegrade double-balloon endoscopy revealed foci of edematous mucosa, with or without villous atrophy, in the non-neoplastic mucosa. Histological studies demonstrated duodenal and intestinal enteropathy-like lesions as well as microscopic (lymphocytic) proctocolitis with increased CD3- and CD8-positive and CD56-negative T-IELs in all four patients. The clinicopathological findings of the non-neoplastic lesions were similar to those characteristic of coeliac disease, suggesting that variants of coeliac disease may be present in the prodromal lesions of MEITL. Our study supports the need for random gastrointestinal biopsies to determine tumor spread, the features of MEITL in the particular patients, and the presence of prodromal non-neoplastic lesions.

17 August 2021 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
YSYuma Sakamoto
Yuma Sakamoto
TITakashi Ishida
Takashi Ishida
AMAyako Masaki
Ayako Masaki
TMTakayuki Murase
Takayuki Murase
MTMorishige Takeshita
Morishige Takeshita
HIHiroshi Inagaki
Hiroshi Inagaki
Summary: Adult T‐cell leukaemia/lymphoma (ATL) patients have a poor prognosis. Here, we investigated the impact of TP53 gene mutations on prognosis of ATL treated in different ways. Among 177 patients, we identified 47 single nucleotide variants or insertion‐deletions (SNVs/indels) of the TP53 gene in 37 individuals. TP53 copy number variations (CNVs) were observed in 38 patients. Altogether, 67 of 177 patients harboured TP53 SNVs/indels or TP53 CNVs, and were categorized as having TP53 mutations. In the entire cohort, median survival of patients with and without TP53 mutations was 1·0 and 6·7 years respectively (P < 0·001). After allogeneic haematopoietic stem cell transplantation (HSCT), median survival of patients with (n = 16) and without (n = 29) TP53 mutations was 0·4 years and not reached respectively (P = 0·001). For patients receiving mogamulizumab without allogeneic HSCT, the median survival from the first dose of antibody in patients with TP53 mutations (n = 27) was only 0·9 years, but 5·1 years in those without (n = 42; P < 0·001). Thus, TP53 mutations are associated with unfavourable prognosis of ATL, regardless of treatment strategy. The establishment of alternative modalities to overcome the adverse impact of TP53 mutations in patients with ATL is required.

18 November 2016 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
KEKozue Ejima-Yamada
Kozue Ejima-Yamada
YOYumi Oshiro
Yumi Oshiro
SOSeiichi Okamura
Seiichi Okamura
TFTomoaki Fujisaki
Tomoaki Fujisaki
YMYasuhito Mihashi
Yasuhito Mihashi
MTMorishige Takeshita
Morishige Takeshita